A faithful in vivo model of human macrophages in metastatic melanoma

Despite recent therapeutic progress, advanced melanoma remains lethal for many patients. The composition of the immune tumor microenvironment (TME) has decisive impacts on therapy response and disease outcome. High dimensional analyses of patient samples can reveal the composition and heterogeneity of the immune TME. In particular, macrophages are known for their cancer-supportive role, but the underlying mechanisms are incompletely understood, and experimental in vivo systems are needed to test the functional properties of these cells. We characterized a humanized mouse model, reconstituted with a human immune system and a human melanoma, in which: (1) human macrophages support metastatic spread of the tumor; and (2) tumor-infiltrating macrophages have a specific transcriptional signature that faithfully represents the transcriptome of macrophages from patient melanoma samples and is associated with shorter survival. This model complements patient sample analyses, enabling the elucidation of fundamental principles in melanoma biology, and the development and evaluation of candidate therapies.

[1]  J. Linton,et al.  Building the Next Generation of Humanized Hemato-Lymphoid System Mice , 2021, Frontiers in Immunology.

[2]  L. Zon,et al.  Melanoma models for the next generation of therapies. , 2021, Cancer cell.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  Xueda Hu,et al.  A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells , 2021, Cell.

[5]  Xianwen Ren,et al.  Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma , 2019, Cell.

[6]  Andrew J. Hill,et al.  The single cell transcriptional landscape of mammalian organogenesis , 2019, Nature.

[7]  I. Amit,et al.  Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma , 2019, Cell.

[8]  A. Rongvaux,et al.  Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models. , 2019, Blood advances.

[9]  J. Schultze,et al.  The Myeloid Cell Compartment-Cell by Cell. , 2019, Annual review of immunology.

[10]  Zemin Zhang,et al.  Understanding tumor ecosystems by single-cell sequencing: promises and limitations , 2018, Genome biology.

[11]  Monika S. Kowalczyk,et al.  A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade , 2018, Cell.

[12]  Carola Berking,et al.  Melanoma , 2018, The Lancet.

[13]  P. Bousso,et al.  A human immune system mouse model with robust lymph node development , 2018, Nature Methods.

[14]  Jennifer L. Guerriero.  Macrophages: The Road Less Traveled, Changing Anticancer Therapy. , 2018, Trends in molecular medicine.

[15]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[16]  J. Banchereau,et al.  Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Yiling Lu,et al.  A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. , 2017, Cell reports.

[18]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[19]  K. Flaherty,et al.  Targeted agents and immunotherapies: optimizing outcomes in melanoma , 2017, Nature Reviews Clinical Oncology.

[20]  Li Wang,et al.  Reversed graph embedding resolves complex single-cell developmental trajectories , 2017, bioRxiv.

[21]  R. Weinberg,et al.  Emerging Biological Principles of Metastasis , 2017, Cell.

[22]  Hans Clevers,et al.  Interrogating open issues in cancer precision medicine with patient-derived xenografts , 2017, Nature Reviews Cancer.

[23]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[24]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[25]  M. Manz,et al.  Generation of Humanized Mice for Analysis of Human Dendritic Cells. , 2016, Methods in molecular biology.

[26]  R. Medzhitov,et al.  Tissue biology perspective on macrophages , 2015, Nature Immunology.

[27]  M. Haniffa,et al.  Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species? , 2015, Front. Immunol..

[28]  P. Linsley,et al.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data , 2015, Genome Biology.

[29]  J. Stender,et al.  Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities , 2015, Cell.

[30]  R. Siliciano,et al.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.

[31]  F. Ginhoux,et al.  New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.

[32]  I. Amit,et al.  Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment , 2014, Cell.

[33]  J. Stender,et al.  Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities , 2014, Cell.

[34]  Florent Ginhoux,et al.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.

[35]  Cole Trapnell,et al.  The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells , 2014, Nature Biotechnology.

[36]  Cole Trapnell,et al.  Pseudo-temporal ordering of individual cells reveals dynamics and regulators of cell fate decisions , 2014, Nature Biotechnology.

[37]  A. Palucka,et al.  Development and function of human innate immune cells in a humanized mouse model , 2014, Nature Biotechnology.

[38]  S. Gordon,et al.  The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.

[39]  Tom C. Freeman,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.

[40]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines , 2013, Nature Immunology.

[41]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[42]  S. Singhal,et al.  Myeloid derived suppressor cells , 2013, Oncoimmunology.

[43]  R. Flavell,et al.  Human hemato-lymphoid system mice: current use and future potential for medicine. , 2013, Annual review of immunology.

[44]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[45]  R. Flavell,et al.  Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. , 2011, Trends in immunology.

[46]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[47]  D. Gabrilovich,et al.  Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.

[48]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[49]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[50]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  H. Møller,et al.  Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  R. DePinho,et al.  BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.

[53]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[54]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[55]  P. Romero,et al.  Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. , 1998, Journal of immunology.